A student-run resource for reliable reports on the latest law and technology news

Archive for the ‘Patent’ Category

Flash Digest: News in Brief
By Kathleen McGuinness

Google News Becomes Opt-In in Germany

Federal Circuit Rules that Software Patent Is Not an “Abstract Idea”

Tokyo Court Rules for Apple, Against Samsung in Bounce-Back Patent Dispute

Read More...

Posted On Jun - 22 - 2013 Comments Off READ FULL POST

Court Dismisses Monsanto Case

Organic Seed Growers v. Monsanto
By Kathleen McGuinness – Edited by Jennifer Wong

The Federal Circuit dismissed a declaratory judgment action against Monsanto for lack of jurisdiction. Monsanto’s assurances constituted a legally binding disclaimer not to sue in cases of inadvertent contamination by their patented seeds. Since the plaintiffs had not removed themselves from the disclaimer’s protection, any “case or controversy” was moot.

Read More...

Posted On Jun - 20 - 2013 Comments Off READ FULL POST

Flash Digest: News in Brief

By Katie Mullen

ITC Ruling May Bar Sales of Some Apple Products in the US

Child Pornography Suspect Granted Temporary Reprieve from Decrypting Hard Drive

White House Calls for Curbing Patent Troll Litigation

Apple and Patent Troll Suing Apple Potentially Represented by the Same Lawyer

Read More...

Posted On Jun - 7 - 2013 Comments Off READ FULL POST

Federal Circuit Finds Bayer’s Yaz Birth Control Patent Invalid for Obviousness

Bayer Healthcare Pharm., Inc. v. Watson Pharm., Inc.
By Erica Larson – Edited by Suzanne Van Arsdale

The Court of Appeals for the Federal Circuit reversed the judgment of the Nevada District Court, which ruled that claims 13 and 15 of Bayer Healthcare Pharmaceuticals, Inc. and Bayer Schering Pharma AG (“Bayer”) U.S. Patent RE37,564 were not invalid for obviousness. The patent claimed a combination of synthetic hormones and dosing regimens used by Bayer in the Yaz birth control pill.

Read More...

Posted On Apr - 30 - 2013 Comments Off READ FULL POST

The Way the Cookie Crumbles: “Metaphorical” Arguments Before The Supreme Court on the Patentability of Genes

Ass’n for Molecular Pathology v. Myriad Genetics, Inc.
By Alex Shank – Edited by David LeRay

On Monday, April 15, the Supreme Court heard oral arguments to determine the validity of a patent encompassing the use of the BRCA1 and BRCA2 genes. Mutations in these genes correlate strongly with the development of breast and ovarian cancers. As the patent owner, Myriad Genetics, Inc. (“Myriad”) possesses and exercises the exclusive right to sell diagnostic testing kits based on these genes.

Read More...

Posted On Apr - 29 - 2013 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
  • GooglePlay
smartflash

Apple Ordered to Pay

By Paulius Jurcys – Edited by Saukshmya Trichi Slip opinion Jury verdict ...

tech-042112-002-617x416

A Computer Programme

By Yaping Zhang – Edited by Jenny Choi On February 13, ...

Unknown

Flash Digest: News i

By Anne Woodworth Report Claims Facebook Privacy Policy in Violation of ...

Unknown

Federal Circuit Flas

By Amanda Liverzani PTO’s Statutory Interpretation on Patent Term Adjustment Upheld  In ...

Unknown

Alleged mastermind b

By Jens Frankenreiter – Edited by Katherine Kwong   U.S. v. ...